During the past decade, Dallas Allergy Immunology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas Allergy Immunology" #1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dallas Allergy Immunology" are "Common Variable Immunodeficiency" (1 trials), "Hyperimmunoglobulin M Syndrome" (1 trials), "Immunologic Deficiency Syndrome" (1 trials), "Primary Immune Deficiency Disorders" (1 trials) and "Primary Immunodeficiency" (1 trials). Many other conditions were trialed in "Dallas Allergy Immunology" in a lesser frequency.

Most popular intervention types in "Dallas Allergy Immunology" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Immune Globulin Intravenous" (1 trials), "Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™" (1 trials), "Prometic's Immune Globulin Intravenous 10%" (1 trials) and "Subgam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Allergy Immunology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Allergy Immunology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dallas Allergy Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Allergy Immunology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".